首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2148330

醫療保健氣味診斷市場：按技術、檢體類型、應用、最終用戶和地區分類

Healthcare Smell Diagnostics Market, By Technology, By Sample Type, By Application, By End User, By Geography

出版日期: 2026年09月30日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，醫療保健氣味診斷市場在 2026 年將達到 2.864 億美元，預計到 2033 年將達到 6.547 億美元。預計從 2026 年到 2033 年，該市場將以 12.5% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2.864億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.50%	2033年市場規模預測：	6.547億美元

全球醫療保健嗅覺診斷市場是一個新興的診斷領域，它分析人體釋放的揮發性有機化合物（VOCs）與疾病之間的關係。電子鼻、氣相層析質譜聯用（GC-MS）、基於感測器的VOC分析和人工智慧平台等技術正被研究用於癌症、呼吸系統疾病、代謝性疾病、神經系統疾病和感染疾病等領域的疾病檢測。

隨著醫療保健系統向非侵入性、早期和個人化診斷轉型，全球醫療保健氣味診斷市場正日益受到關注。感測器技術、人工智慧和揮發性有機化合物（VOC）分析技術的進步，提高了檢測疾病特異性分子模式的能力，推動了利用呼吸和生物體液進行快速診斷方法的發展。

市場動態

全球醫療保健氣味診斷市場的發展動力主要來自對非侵入性早期診斷日益成長的需求，尤其是在呼吸系統、代謝性疾病、神經系統疾病、感染疾病和癌症相關疾病領域。將人工智慧和機器學習技術與電子鼻和揮發性有機化合物 (VOC) 分析平台相結合，有望透過即時分析提高模式識別和診斷準確性。此外，人們對攜帶式和即時診斷的興趣日益濃厚，預計也將進一步推動醫療保健氣味診斷技術的應用。

然而，醫療保健嗅覺診斷市場的成長受到許多因素的限制，例如缺乏監管標準化、揮發性有機化合物（VOC）測量結果缺乏可重複性、技術成本高昂以及許多應用缺乏臨床有效性。儘管如此，在亞太、拉丁美洲和中東地區，隨著新型診斷應用、人工智慧平台、策略聯盟的開發以及先進診斷技術的日益普及，該市場仍蘊藏著巨大的發展機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於以下參數分析了全球醫療保健嗅覺診斷市場的主要參與者：公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份《全球醫療保健氣味診斷市場》報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球醫療保健氣味診斷市場中使用的各種策略矩陣，相關人員將能夠做出更順利的決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

Owlstone Medical Limited
Breathomix BV
Breath Diagnostics, Inc.
eNose Company BV
Ainos, Inc.
The eNose Company
Mistral Srl
Nanose Medical Ltd.
AIREX Inc.
Ancon Medical Limited

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI10174

Healthcare Smell Diagnostics Market is estimated to be valued at USD 286.4 Mn in 2026 and is expected to reach USD 654.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 286.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.50%	2033 Value Projection:	USD 654.7 Mn

The global healthcare smell diagnostics market is an emerging diagnostic field that analyzes volatile organic compounds (VOCs) emitted by the human body that are associated with diseases. Technologies such as electronic nose, GC-MS, sensor-based VOC analysis and AI-enabled platforms are being explored for detection of diseases like cancer, respiratory diseases, metabolic disorders, neurological diseases and infections.

The global healthcare smell diagnostics market is gaining attention as healthcare systems are moving toward non-invasive, early and personalized diagnostics. Advances in sensor technology, AI and VOC profiling are enhancing the ability to detect disease-specific molecular patterns in support of the development of rapid breath- and biofluid-based diagnostic approaches.

Market Dynamics

The global healthcare smell diagnostics market is driven by the increasing incidence of disease diagnosis through non-invasive and early diagnosis, especially for respiratory, metabolic, neurological, infectious and cancerous diseases. The integration of artificial intelligence and machine learning along with electronic nose and volatile organic compound analysis platforms is expected to improve pattern recognition and diagnostic accuracy with real-time analysis. The increasing interest for portable and point of care diagnostics is expected to further propel the adoption of healthcare smell diagnostics.

However, the growth of healthcare smell diagnostics market is limited by factors such as absence of regulatory standardization, lack of reproducibility in VOC measurements, high cost of technology, and lack of clinical validation for many applications. Nevertheless, significant opportunities exist in the development of novel diagnostic applications, AI-based platforms, strategic collaborations, and increasing adoption of advanced diagnostics in Asia Pacific, Latin America, and the Middle East.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global healthcare smell diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Owlstone Medical Limited, Breathomix B.V., Breath Diagnostics, Inc., eNose Company B.V., Ainos, Inc., The eNose Company, Mistral S.r.l., Nanose Medical Ltd., AIREX Inc., and Ancon Medical Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global healthcare smell diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare smell diagnostics market

Market Segmentation

Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Electronic Nose (E-Nose)
- Gas Chromatography-Mass Spectrometry (GC-MS)
- Sensor-Based VOC Analysis
- Mass Spectrometry-Based Analysis
- Others
Sample Type Insights (Revenue, USD Mn, 2021 - 2033)
- Exhaled Breath
- Blood
- Urine
- Saliva
- Others
Application Insights (Revenue, USD Mn, 2021 - 2033)
- Cancer Detection
- Respiratory Disease Detection
- Infectious Disease Detection
- Metabolic Disease Detection
- Gastrointestinal and Liver Disease Detection
- Neurological Disease Detection
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Owlstone Medical Limited
- Breathomix B.V.
- Breath Diagnostics, Inc.
- eNose Company B.V.
- Ainos, Inc.
- The eNose Company
- Mistral S.r.l.
- Nanose Medical Ltd.
- AIREX Inc.
- Ancon Medical Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Healthcare Smell Diagnostics Market, By Technology
- Global Healthcare Smell Diagnostics Market, By Sample Type
- Global Healthcare Smell Diagnostics Market, By Application
- Global Healthcare Smell Diagnostics Market, By End User
- Global Healthcare Smell Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Technology Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Healthcare Smell Diagnostics Market, By Technology, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Electronic Nose (E-Nose)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gas Chromatography-Mass Spectrometry (GC-MS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Sensor-Based VOC Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Mass Spectrometry-Based Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Healthcare Smell Diagnostics Market, By Sample Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Exhaled Breath
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Saliva
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Healthcare Smell Diagnostics Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cancer Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Respiratory Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Infectious Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Metabolic Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Gastrointestinal and Liver Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Neurological Disease Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Healthcare Smell Diagnostics Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Healthcare Smell Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Owlstone Medical Limited
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
Breathomix B.V.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
Breath Diagnostics, Inc.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
eNose Company B.V.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
Ainos, Inc.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
The eNose Company
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
Mistral S.r.l.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
Nanose Medical Ltd.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
AIREX Inc.
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies
Ancon Medical Limited
- Company Highlights
- Technology Portfolio
- Key Developments
- Financial Performance
- Strategies